Lighthouse Pharmaceuticals

Precision medicine for major unmet medical needs

Novato, United States · $61.2M raised

Headquarters
Novato
Business Model
B2B
Total Funding
$61.2M
Last Round
$12.0M Series AApr 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Lighthouse Pharmaceuticals is a clinical-stage biopharmaceutical company based at the Buck Institute for Research on Aging in Novato, California, developing small-molecule therapeutics for chronic neurodegenerative and neuropsychiatric diseases. Its lead program, LHP588, is a next-generation gingipain inhibitor in Phase 2 trials (SPRING) for P. gingivalis-positive mild to moderate Alzheimer's disease, backed by a $49.2 million NIA grant, and it licensed a related periodontal-health asset for dogs to Phibro Animal Health.

Summary

Lighthouse Pharmaceuticals is a Biotech company based in Novato, United States. It has raised $61.2M in total across 2 rounds, most recently a $12.0M Series A round in Apr 2026. Investors include Double Point Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2026
$12.0M

Sign up to see all 2 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lighthouse Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/lighthouse-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/lighthouse-pharmaceuticals" alt="Lighthouse Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>